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Abstract
Background:  To study the effects of a pre-germinated brown rice diet (PR) on diabetic
neuropathy in streptozotocin (STZ)-induced diabetic rats.
Methods: The effects of a PR diet on diabetic neuropathy in STZ-induced diabetic rats were
evaluated and compared with those fed brown rice (BR) or white rice (WR) diets with respect to
the following parameters: blood-glucose level, motor-nerve conduction velocity (NCV), sciatic-
nerve Na+/K+-ATPase activity, and serum homocysteine-thiolactonase (HTase) activity.
Results: Compared with diabetic rats fed BR or WR diets, those fed a PR diet demonstrated
significantly lower blood-glucose levels (p < 0.001), improved NCV (1.2- and 1.3-fold higher,
respectively), and increased Na+/K+-ATPase activity (1.6- and 1.7-fold higher, respectively). The PR
diet was also able to normalize decreased serum homocysteine levels normally seen in diabetic rats.
The increased Na+/K+-ATPase activity observed in rats fed PR diets was associated with elevations
in HTase activity (r = 0.913, p < 0.001). The in vitro effect of the total lipid extract from PR bran
(TLp) on the Na+/K+-ATPase and HTase activity was also examined. Incubation of homocysteine
thiolactone (HT) with low-density lipoprotein (LDL) in vitro resulted in generation of HT-modified
LDL, which possessed high potency to inhibit Na+/K+-ATPase activity in the sciatic nerve
membrane. The inhibitory effect of HT-modified LDL on Na+/K+-ATPase activity disappeared when
TLp was added to the incubation mixture. Furthermore, TLp directly activated the HTase
associated with high-density lipoprotein (HDL).
Conclusion: PR treatment shows efficacy for protecting diabetic deterioration and for improving
physiological parameters of diabetic neuropathy in rats, as compared with a BR or WR diet. This
effect may be induced by a mechanism whereby PR intake mitigates diabetic neuropathy by one or
more factors in the total lipid fraction. The active lipid fraction is able to protect the Na+/K+-
ATPase of the sciatic-nerve membrane from the toxicity of HT-modified LDL and to directly
activate the HTase of HDL.
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Background
Pre-germinated brown rice (PR), prepared by soaking
brown rice (BR) in 37°C water for 24 h to initiate germi-
nation of sprouts not exceeding 0.5-mm in length [1], is a
commercial dietary supplement in Japan. The efficacy of
PR-enriched diets in reducing blood glucose levels in
streptozotocin (STZ)-induced diabetic rats has been
reported [2]. STZ, which induces type 1 diabetes mellitus
when delivered to rats, is a useful etiological model for
studying complications caused by diabetic hyperglycemia.
In clinical studies, we previously showed that both non-
diabetic patients and hyperglycemic patients with uncon-
trolled diabetes who ate diets supplemented with PR had
lower postprandial blood-glucose levels than those who
ate white rice (WR)-supplemented diets [3,4]. It has been
suggested that the reduction in blood- glucose levels and
the incidence of diabetic vascular complications in dia-
betic patients fed a PR-rich diet may result from the sub-
stantially higher dietary fiber content of germinating rice
bran [5]. However, the γ-aminobutyric acid (GABA) pro-
duced during germination of BR or the vitamins, minerals
and/or unknown bioactive lipids in the bran and germ
layer of PR may also be associated with PR's effect on
blood-glucose levels [6,7]. Reduced type-1 plasminogen-
activator inhibitor and lipid-peroxide levels have been
reported in diabetic rats [2], suggesting that PR intake may
ameliorate diabetic vascular complications such as retin-
opathy and nephropathy.
Another major complication of diabetes is peripheral neu-
ropathy, which occurs in greater than 50% of diabetics.
Early nervous system dysfunctions in diabetics include
reduced nerve conduction velocity (NCV), which fre-
quently is followed by axonal degeneration and paran-
odal demyelination [8]. It is of interest, therefore, to
compare PR and BR diets during the development of dia-
betic neuropathy. We undertook a study to investigate the
difference in the effectiveness of PR and BR diets in rats
with STZ-induced diabetic neuropathy.
The neuropathy seen in the well-characterized STZ-
induced diabetic rat model shares many of the same path-
ological, functional, and biochemical alterations seen in
human diabetic [9,10]. In particular, gradual decreases in
Na+/K+-ATPase activity and NCV are observed in the sci-
atic nerves of STZ-treated rats. Recent findings suggest that
depressed activity of Na+/K+-ATPase, a plasma membrane-
bound enzyme, is a hallmark of diabetic neuropathy [11].
PR-enriched diets have shown promise in ameliorating
many vascular diabetic sequelae in human patients
according to Japanese folk medicine; however, there is lit-
tle systematic scientific study regarding its nutritional
functions. We were interested in investigating the compar-
ative effects of PR- and BR-enriched diets on the develop-
ment of diabetic neuropathy in STZ-induced diabetes in
rats. We decided to investigate the effect of PR- and BR-
enriched diets specifically on NCV and sciatic nerve Na+/
K+-ATPase activities in STZ-induced diabetes in rats.
Diabetic neuropathy is also thought to develop as a result
of damage caused by oxidative stress and other vascular
risk factors [12,13]. Homocysteine-thiolactone (HT) is
formed from an excess amount of serum homocysteine
(Hcy) and causes protein homocysteinylation and subse-
quent protein damage. In particular, homocysteinylated
low-density serum lipoproteins (LDLs) are more suscepti-
ble to lipid peroxidation. On the other hand, high-density
lipoproteins (HDLs) are resistant to homocysteinylation
because of an associated homocysteine-thiolactonase
(HTase) that hydrolyzes HT; this hydrolysis prevents sub-
sequent HDL lipid peroxidation. HT is reported to pro-
duce oxidative stress in rat hippocampal neurons by
inhibiting Na+/K+-ATPase activity [14,15]. Further,
Vignini et al. [16] reported that HT-modified LDL attenu-
ates Na+/K+-ATPase activity in cultured human aortic
endothelial cells.
HT is thought to be an endogenous substrate for three iso-
zymes of the serum esterase paraoxonase (PON): PON1,
PON2, and PON3 [17]. PON1 has been shown to be
involved in the detoxification of various organophos-
phatases, such as nerve gases, dietary neurotoxins, or toxic
lipids produced during oxidative stress [18]. Serum PON1
activity is decreased in type 2 diabetic patients with
atherosclerosis [19] and in STZ-induced type 1 diabetic
rats [20]. Decreased PON1 activity is also observed in
patients with type 1 and type 2 diabetic peripheral neu-
ropathy, suggesting that diabetic neuropathy may also
arise, in part, due to the increased susceptibility of the
nervous system to neurotoxic damage resulting from the
lack of protection in diabetics normally afforded by PON1
in non-diabetics [21]. The role of PON1 activity in HDL in
diabetes has become an important concern [22,23]. For
this reason, HTase activity can be another important
biomarker for evaluating diabetic neuropathy, especially
when estimation of this enzyme activity requires HT to be
a natural substrate. To assess the effects of a PR-enriched
diet on the development of diabetic neuropathy, we also
evaluated the effect of PR- and BR-enriched diets on serum
PON1 activities in STZ-induced diabetic rats.
In addition, circumstantial evidence suggests that other
bioactive components are present in PR bran that are
more potent than GABA in alleviating diabetic neuropa-
thy. To test this possibility, we isolated the total lipid
extracts (TLp) from PR and BR and compared the effects
of these lipid fractions on HTase activity.Nutrition & Metabolism 2007, 4:25 http://www.nutritionandmetabolism.com/content/4/1/25
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Methods
STZ-induced diabetic rats and experimental diets
Male Wistar rats, weighing 120–140 g, received intra-peri-
toneal injections of STZ (65 mg/kg in 100 mM sodium cit-
rate buffer, pH 4.5). The use of these animas had been
approved by Medical College of Georgia's Institutional
Animal Care and Use Committee. Beginning 1 week after
STZ injection, blood samples were obtained at each time
point from the same rats following a 15-hour starvation
period by pricking the tip of the rat tail and bleeding a
drop (about 0.06 ml) of blood. The whole blood was
obtained from each rat by heart puncture at the endpoint
of the experiment. The blood-glucose levels were meas-
ured using a strip-operated blood glucose meter (Accu-
Chek Advantage Blood Glucose Meter, Roche Diagnostics,
Indianapolis, IN). Two animals were housed per cage in a
controlled environment. All animals were allowed free
access to water and food, except during the starvation peri-
ods just prior to blood glucose assessments.
All rice and control diets were manufactured as powdered
feed by Harlan Teklad (Madison, WI). The control diet
(AIN93G) was composed of cornstarch [39.7% (w/w)], α-
cornstarch [13.2% (w/w)], casein [20.0% (w/w)], L-
cysteine [0.3% (w/w)], sucrose [10% (w/w)], soybean oil
[7.0% (w/w)], cellulose powder [5.0% (w/w)], mineral
mix [3.5% (w/w)], vitamin mix [1.0% (w/w)], choline
bicitrates [0.25% (w/w)], and_butylhydroquinone
[0.0014% (w/w)]. Pre-germinated brown (PR), brown
(BR), or white (WR) rice diets were produced by replacing
cornstarch and α-cornstarch with pre-germinated brown,
brown, or white rice, respectively (Table 1).
Animal experiment design
Male Wistar rats (n = 40) received intra-peritoneal injec-
tions of STZ and were maintained on AIN93G for 2 weeks.
Only those animals whose blood glucose levels were >
400 mg/dl were considered diabetic. The diabetic rats (n =
31) were divided into four experimental groups: the DWR
(n = 9), DBR(n = 9), and DPR (n = 9) groups received WR-
, BR-, and PR-enriched diets, respectively, and DC group
(n = 4) were fed AIN93G. Non-diabetic rats (n = 22) were
also divided into four feeding groups: the WR (n = 6), BR
(n = 6), and PR (n = 6)groups received WR-, BR-, and PR-
enriched diets, respectively, while the C control group (n
= 4) received AIN93G.
Because rats became moribund with severe diabetic dete-
rioration initiating 3 weeks after STZ injection, the exper-
imental endpoint was designated 3 weeks after initiation
of the rice-enriched diet regimens (i.e., 5 weeks after STZ-
injection). Food consumption was measured by weighing
the feeding containers daily. Three weeks after initiation
of the rice-enriched diets, tail-nerve conduction electro-
physiological studies were performed, and then the rats
were sacrificed. Whole serum samples were obtained for
biochemical analyses as described below. The sciatic
nerves were removed; the right sciatic nerve was utilized
for morphometric studies while the left sciatic nerve was
assayed for Na+/K+-ATPase activities.
Nerve-conduction velocity measurements
Nerve-conduction velocities (NCVs, m/sec) were assessed
in the rat tail nerve using a Nicolet VikingQuest EMG
machine (Neurocaregroup, Madison, WI) according to
the modified procedure of Anderson et al. [24]. In brief,
the nerves were stimulated using external digital ring elec-
trodes with twisted wires (Medtronic Functional Diagnos-
tics, Skovlunde, Denmark) instead of needle electrodes
[25]. The electrodes were placed in segments proximal (5
cm) and distal (2 cm) from the recording position (7 cm
far from the joint of rat tail). Blood collection was from
the tip of the tail that was distant and non-interactive with
NCV measurement. NCV was evaluated from four differ-
ent waves generated from electrical stimulations; each
wave showed a reproducible pattern and the same ampli-
tude level as the stimulator-voltage was increased. During
each measurement, a constant surface temperature of the
rat tail was maintained (34–35°C). NCV values represent
an average value from 4 nerve conduction wave measure-
ments per animal.
Morphometric analysis
The right sciatic nerves were carefully dissected from their
origin (5 mm distal to the gluteus maximus) through the
distal branch point at the peroneal and tibial nerves in
order to avoid stretching. These nerve sections were placed
overnight in a fixative solution containing paraformalde-
hyde. After washing 3 times in cacodylate buffer (pH 7.2),
Table 1: Com position of experim ental diets (g/100 g)
Ingredient AIN93G WR BR PGR
Protein 17.7 21.5 21.6 21.8
Fat 7.2 7.0 8.3 8.1
Available carbohydrate 55.1 53.4 50.0 50.4
Dietary fiber 5.0 5.6 6.5 6.7
Total energy(kcal/100 g) 366.0 373.8 374.1 375.1
Values are calculated from ingredient analysis or m anufacturer dataNutrition & Metabolism 2007, 4:25 http://www.nutritionandmetabolism.com/content/4/1/25
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the nerves were cross-sectioned into two pieces and
embedded in epoxy resin (Poly/Bed 812, Polysciences
Inc., Warrington, PA). Fascicle cross sections were stained
with 1% toluidine blue and observed under an Axiophot
photomicroscope equipped with an Axiocam (Carl Zeiss,
Jena, Germany). Images were stored and analyzed using
AxioVision. The total number of myelinated fibers in each
fascicle was assessed by visual counting. In myelinated
fibers, both the axonal and total fiber diameters were
measured, based on the average of the major and minor
diameters. Diameters of the myelinated fibers and axons,
as well as the G ratio (axonal diameter/total fiber diame-
ter, a measure of the degree of myelination), were
obtained, and histograms of their distributions and the G
ratios were constructed as percentages of size frequency.
Total lipid preparation
The total lipid fractions from PR and BR bran (TLp and
TLb, respectively) were prepared by extracting 5 g of bran
twice with 30 ml and 20 ml of chloroform-methanol (1:1
(v/v) and 2:1 (v/v), respectively) using the procedure of
Folch et al. [26]. Lipid fractions from these two extractions
were combined, evaporated, and used in in vitro enzyme
assays.
Lipoprotein separation
Lipoprotein fractions were prepared from rat serum using
previously published procedures [27]. Briefly, freshly col-
lected serum obtained from normal male Wistar rats (n =
4) was pooled and adjusted to a density of 1.3 g/ml with
solid potassium bromide. A discontinuous density gradi-
ent was formed in a centrifuge tube by layering normal
saline (3.5 ml, 1.006 g/ml) over the adjusted serum (1.5
ml, 1.3 g/ml). Lipoproteins were separated by ultracentrif-
ugation (370,000 × g, 45 min, 4°C) in a TV865 rotor.
Three major lipoprotein fractions (VLDL, LDL, and HDL)
were collected and dialyzed overnight against PBS at 4°C.
Sciatic nerve membrane preparation for the Na+/K+-
ATPase assay
Crude sciatic nerve membranes were prepared from each
rat of the diet experiment using a previously published
procedure [28]. Briefly, the left sciatic nerve from rats fed
WR-, BR-, or PR-enriched diets, or AIN93G, or from
untreated male Wistar rats were homogenized in Polytron
homogenizer in a cold iso-osmotic solution containing
250 mM sucrose, 10 mM HEPES-Tris buffer (pH 7.6),
EDTA 2 mM, and PSMF 1 mM. The homogenates were
centrifuged for 10 min at 1,500 × g at 4°C; the superna-
tants were collected and then centrifuged at 191,000 × g
for 45 min at 4°C. After decanting the supernatant, the
pellets were resuspended in 100 µl of 250 mM sucrose in
10 mM HEPES-Tris buffer (pH 7.6).
Na+/K+-ATPase assay
Na+/K+-ATPase activities were assayed as previously
described [28]. Briefly, a 0.2 ml assay medium containing
10 mM MgCl2, 20 mM HEPES-Tris (pH 7.0), 120 mM
NaCl, 30 mM KCl, 0.5 mg/ml of crude membrane prepa-
rations, and 25 mM [γ-32P]ATP (100,000 cpm) were incu-
bated at 37°C for 15 min, followed by the addition of 0.1
ml of activated carbon (0.1 mg/ml). Parallel assays were
also performed in which 1 mM ouabain was added to the
assay medium. Following the addition of activated car-
bon, the samples were centrifuged at 1,500 × g for 15 min
at 4°C, the supernatants were collected, and the cpm of
the inorganic 32P radioactivity in the fractions was meas-
ured using a Beckman scintillation counter. Ouabain-sen-
sitive Na+/K+ ATPase activity was calculated by subtracting
the ouabain-sensitive activity from the Na+/K+-enhanced
activity.
Paraoxonase 1 (PON1) activity assays
PON1 activity was measured in 96-well ELISA plates; each
well contained 20 µl of rat serum (diluted 1:4 in Tris-HCl
buffer) and 200 µl of substrate solution containing 5.5
mM paraoxoethyl and 2 mM CaCl2 in 100 mM Tris-HCl
buffer (pH 8.0). Generation of p-nitrophenol was moni-
tored as a function of time at 25°C by recording the
absorbance at 412 nm using a spectrophotometer.
Enzyme activities were calculated using the molar absorp-
tion coefficient of p-nitrophenol (ε412
M, 169,000 M-1 cm-
1).
Homocysteine-thiolactonase (HTase) activity assays
HTase activities in rat serum or in HDL fractions from nor-
mal male Wistar rats were measured with a commercial
assay kit (Alfresa Auto HTLase; Alfresa Pharma Corp.,
Osaka, Japan) [23] that utilizes γ-thiobutyrolactone as the
substrate. HTase hydrolyzes the lactone ring, generating
free thiol, which reacts with 5, 5'-dithio-bis (2-nitroben-
zoic acid). Generation of 5-thio-2-nitrobenzoic acid was
monitored as a function of time by recording the absorb-
ance at 450 nm using a spectrophotometer.
Incubation of homocysteine-thiolactone (HT) with low-
density lipoprotein (LDL)
In vitro homocysteinylation of LDL was done according to
the procedure of Vignini et al. [16]. Briefly, an aliquot of
LDL (100 µg) was resuspended in 10 mM PBS (pH 8.2)
and incubated with homocysteine-thiolactone (100
µmol/L, Sigma, St. Louis, MO) and the indicated amount
(0.1 to 1.0 µg) of a total lipid fraction (TLb or TLp) with
gentle stirring at 37°C for 2 h. After incubation, the mix-
ture was passed through a Bio-gel P-2 column equili-
brated with 10 mM PBS (pH 8.2) to remove any unreacted
HT.Nutrition & Metabolism 2007, 4:25 http://www.nutritionandmetabolism.com/content/4/1/25
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Serum creatinine determination
The creatinine concentrations in rat serum samples were
assayed by Jaffe's alkaline-picrate method as described by
Adeoye et al. [29]. Proteins were precipitated from 1 ml of
serum by the addition of 1 ml 10% sodium tungstate in 1
ml of 0.67 M sulfuric acid, and the supernatants were col-
lected;1.5 ml of the supernatants were mixed with 0.5 ml
of 2.5 M NaOH and 0.5 ml of 0.04 M picric acid, and then
incubated for 5 min at 25°C. The absorbance at 520 nm
was measured in each sample against a blank that con-
sisted of distilled water with the reagent as described
above using a spectrophotometer.
Statistical analysis
Statistical analyses were performed for animal data using
the GraphPad Prism 2.01 software package (GraphPad,
San Diego, CA). Differences among diet groups with non-
diabetic treatment or with diabetic treatment were ana-
lyzed using the one-way ANOVA (Table 2) test. Normali-
zation of data distribution was given by Prism 2.01 before
the comparison test. If the data were found to be paramet-
ric, they were analyzed by Tukey's multiple comparison
test, followed by determination of differences vs. the con-
trol group after obtaining a significant ANOVA by the
Dunnet's test. If the data were non-parametric, they were
analyzed by the Kruskal-Wallis test of one way analysis of
variance on rank, followed by Dunn's multiple compari-
son test. Differences among the diet treatment groups
were considered significant if p < 0.01. For comparisons of
size-frequency distributions, the difference of skewness
was evaluated by the chi-square test for trend in the Prism
2.01 to evaluate the statistical difference of skewness. A
value of p < 0.01 was considered a statistically significant
difference.
In correlation analyses, Pearson correlation coefficients
were calculated to identify potential associations of the
HTase, PON1, NCV, and Na+/K+-ATPase activities. A value
of p < 0.05 was considered a statistically significant differ-
ence. Data were presented as mean ± standard error of the
mean (SEM).
Results
Body weight and blood-glucose level
The total mass of food consumed during the 3-week
experimental diet period for each non-diabetic rat group
was as follows: WR, 590 ± 31 g; BR, 611 ± 42 g; and PR,
631 ± 64 g. The total mass of food consumed during the
same period for each diabetic rat group was as follows:
DWR, 641 ± 58 g; DBR, 658 ± 30 g; and DPR 631 ± 53 g.
The consumption rates were not significantly different
among the normal and diabetic rats fed WR-, BR-, and PR-
enriched diets (assessed by the Kruskal-Wallis test fol-
lowed by Dunn's test).
The body-weight gain in the WR, BR, and PR groups was
smooth, and no differences were observed among the
three groups. Modest body-weight gain due to diabetes
was observed in the DWR, DBR, and DPR groups, and
considered to be a well-established phenomenon in insu-
lin-deficiency caused by STZ treatment in the rat [30].
There were also no statistically significant differences in
body-weight gain between rats fed a rice-enriched diet and
those fed the control AIN93G diet. The DPR group, how-
ever, had statistically significant body-weight gain as com-
pared with the DC group (p < 0.01, Dunnett's test) but not
with the DBR group, as shown in Table 2.
All the blood-glucose levels of the non-diabetic AIN93G-
and rice-diet groups (C, PR, BR and WR) were within the
normal range during the experimental period (Table 2). In
Table 2: Final body weights, blood glucosse concentrations, and peripheral nerve or serum parameters in non-diabetic and diabetic 
rats (3 weeks) sacrificed at the end of the diet-feeding experiment
Treatment Non-diabetic Diabetic
Diet C WR BR PR C WR BR PR
Group C WR BR PR DC DWR DBR DPR
Number of animals 4 6 6 6 4 9 9 9
Weight (g) 373.8 ± 7.8 374.7 ± 3.8 370.3 ± 9.1 384.8 ± 13.5 174.0 ± 8.6 174.2 ± 4.8 183.9 ± 2.7 b 209.0 ± 3.3 a*
Glucose (mg/dl) 127.0 ± 1.8 135.5 ± 2.7 129.0 ± 3.3 126.7 ± 4.0 438.0 ± 11.0 431.0 ± 9.3 405.2 ± 9.1 351.9 ± 6.3 a*
NCV (m/s) 50.4 ± 0.8 49.9 ± 1.3 50.2 ± 0.8 50.4 ± 0.9 34.0 ± 1.4 34.4 ± 0.8 37.9 ± 1.1 44.5 ± 1.3 a*
Na+/K+- ATPase (µmol/g/h) 6102.5 ± 218.9 4855 ± 463.4 6998 ± 515.6 6302 ± 371.5 2238 ± 102 2229.3 ± 153.0 2437.2 ± 189.9 3867.8 ± 177.6 a*
Homocysteine (µM) 6.3 ± 0.3 5.9 ± 0.1 6.1 ± 0.2 6.3 ± 0.2 3.3 ± 0.2 3.1 ± 0.2 4.2 ± 0.1 b*5 . 3  ±  0 . 1  a*
PON 1 (nmol/ml/min) 224.0 ± 11.1 217.9 ± 4.4 216.0 ± 4.6 239.5 ± 6.5 118.4 ± 7.4 117.4 ± 5.9 158.3 ± 8.4 a 187.7 ± 13.6 a*
HTase (nmol/mg/min) 9.8 ± 0.4 10.0 ± 0.2 10.2 ± 0.3 10.3 ± 0.3 2.0 ± 0.3 c 1.8 ± 0.2 c 4.3 ± 0.2 b** 8.9 ± 0.2 a**
Creatinine (µmol/l) 67.3 ± 1.7 60.3 ± 1.6 59.7 ± 1.3 a* 59.5 ± 1.0 a* 89.3 ± 1.7 88.3 ± 1.1 a 82.5 ± 1.3 b* 72.8 ± 1.1 c*
One-way ANOVA was performed for 4 groups of non-diabetic treatment or diabetic treatment, followed by Tukey's multiple comparison test (if 
parametric). Difference vs. control (C group or DC group) was analyzed by Dunnet's multiple comparison test (*P < 0.01, **P,0.001). Kruskal-
Wallis test was performed for the groups (if non-parametric) followed by Dunn's multiple comparison test. Values are means ± SEM. a,b,cValues with 
different superscript letters are significantly different among the same column at P < 0.01.Nutrition & Metabolism 2007, 4:25 http://www.nutritionandmetabolism.com/content/4/1/25
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contrast, the blood-glucose levels of the diabetic rats fed
the AIN93G, WR-, BR-, or PR-enriched diets (i.e., DC,
DWR, DBR, and DPR groups, respectively) were elevated.
During the initial week of the rice-enriched diet regimen,
all diabetic groups demonstrated high blood-glucose lev-
els (Table 2); after 3 weeks of the rice-enriched diets, how-
ever, the blood glucose levels of the DPR group were
significantly lower than those of the DWR and DBR
groups (p < 0.001, Tukey's test), as shown in Table 2.
Amelioration of peripheral nerve dysfunction
A positive correlation was established between values for
NCV and Na+/K+-ATPase activities in non-diabetic and
STZ-diabetic rats (Fig. 1). The data also include rats fed by
a regular diet (AIN93G). This result demonstrates that
decreased sciatic-nerve Na+/K+-ATPase activities are likely
to result in electrophysiological and neurophysiological
abnormalities. Comparison of the effects of the diet
intakes on NCV and Na+/K+-ATPase activity is shown in
Table 2, expressed as mean ± SEM. Diabetic rats fed the
control diet (AIN93G) showed significantly decreased
NCVs when compared with those in the non-diabetic rats.
NCVs in the DPR group, on the other hand, were signifi-
cantly faster than those observed in the DC, DWR or DBR
group (p < 0.001, Tukey's test). Na+/K+-ATPase activities in
the DPR group were also significantly higher than those
seen in the DBR, DWR, and DC groups (p < 0.001, Tukey's
test), as shown in Table 2.
Morphometric analysis of sciatic nerve
Size-frequency distribution histograms for myelinated
fiber diameter, myelinated axon diameter, and the G ratio
in rat sciatic nerves were evaluated by the chi-square test
for trend in the Prism 2.01, and compared among three
groups: a non-diabetic group fed the AIN93G diet (C
group); a diabetic group fed the AIN93G diet (DC group);
and a diabetic group fed the PR diet (DPR group). There
was no statistically significant difference between myeli-
nated fiber distributions; one difference between axonal
distributions for the C and DC groups, however, indicated
that the STZ rat model of diabetes primarily affected
axons. Since the G ratio is a reflection of the diameters of
axons and myelinated fibers, these observations indicate
that PR intake could prevent or correct myelinated axonal
injury in the STZ model of diabetic neuropathy (data not
shown).
PON1 and HTase
Serum activities for creatinine or PON1 and HTase in the
diabetic and non-diabetic animals are shown in Table 2 as
means ± SEM. Given that the non-diabetic groups had
similar weight gains and diet consumptions, we cannot
attribute the changes in serum homocysteine concentra-
tions to differences in vitamin or amino-acid intake in the
rice diets. The decreased homocysteine levels in the dia-
betic rats indicate that increased creatinine levels may
reflect diabetic complications such as nephropathy. The
serum homocysteine level and PON1 activity in the DPR
group sera were affected by STZ-induced diabetes, which
was not the case in the DC, DWR and DBR groups (p <
0.001, Tukey's test) (Table 2).
To determine whether the PR-diet promoted amelioration
of the nervous function by a specific active component of
PR due to an HT-related mechanism, a correlation analy-
sis was performed between activities of Na+/K+-ATPase
and HTase (or PON1) for each group of Table 2. A positive
correlation was established between activities of serum
HTase and PON1 in all the diet-treated and the control
groups (r = 0.819 to 0.992). On the other hand, a positive
correlation between Na+/K+-ATPase and HTase activities
was established only in the DPR (r = 0.913, p < 0.001) and
PR groups (r = 0.878, p < 0.05). Other diet-treated groups
showed no correlation between the two enzyme activities.
Although the DBR group showed an improvement in dia-
betic neuropathy, there was no correlation between the
two enzyme activities in DBR group (r = -0.217, non-sig-
nificant) and BR group (r = -0.142, non-significant).
Homcysteine-thiolactonation of LDL
HT causes LDL deterioration, resulting in the develop-
ment of diabetic complications as a vascular risk factor by
HT-modified LDL. HTase is present in serum HDL and has
an important role in the antioxidation of LDL. We
hypothesized that the efficacy of a PR diet on diabetic neu-
ropathy might be dependent on an HT-related mecha-
nism. To test this possibility, an additional effect of rice
Correlation of NCV and sciatic-nerve membrane Na+/K+- ATPase activities in non-diabetic rats (n = 22) and STZ- induced diabetic rats (n = 31) Figure 1
Correlation of NCV and sciatic-nerve membrane Na+/K+-
ATPase activities in non-diabetic rats (n = 22) and STZ-
induced diabetic rats (n = 31). Non-diabetic rats consisted of 
C-group (n = 4), WR-group (n = 6), BR-group (n = 6), and 
PR-group (n = 6). STZ-diabetic rats consisted of DC-group 
(n = 4), DWR-group (n = 9), DBR-group (n = 9), and DPR-
group (n = 9). Regression lines are shown for analyses that 
include all data points (n = 22 and n = 31). Pearson's correla-
tion coefficients (r) were used to evaluate simple linear rela-
tionship between variables.Nutrition & Metabolism 2007, 4:25 http://www.nutritionandmetabolism.com/content/4/1/25
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bran lipid extracted fractions (TLp or TLb) on Na+/K+-
ATPase activity was tested with HT-treated LDL. Changes
in the Na+/K+-ATPase activity of normal rat sciatic nerve
was studied by incubation of HT-treated LDL with HT and
TLp or TLb (Fig. 2A). A significant decrease in Na+/K+-
ATPase activity occurred in an in vitro system incubated
with HT-modified LDL as compared with intact LDL.
Incubation with TLp (0.1 µg to 10 µg) attenuated the
inhibitory activity of HT-modified LDL on Na+/K+-ATPase
activity (columns 7 to 9, Fig. 2A), whereas TLb had no
effect on the inhibition of Na+/K+-ATPase activity by HT-
modified LDL (columns 4 to 6, Fig. 2A). Neither TLp nor
TLb alone produced any modification of Na+/K+-ATPase
activity (data not shown). The effect of TLp suggests the
presence of an inhibitory factor causing normalization of
Na+/K+-ATPase activity that has been blocked by HT-mod-
ified LDL.
HTase activity of HDL
In the previous experiment, we showed that Na+/K+-
ATPase activity was controlled by HT-modified LDL. The
efficacy of PBR on diabetic neuropathy may be related to
the HTase activity of HDL on an HT-related mechanism.
To verify this possibility, the effect of rice bran lipid
extracted fractions (TLp or TLb) on HTase activity was
tested. HDL prepared from normal male Wistar rat serum
was used as an enzyme source of HTase as described in the
Methods section. HTase activity in the presence of TLp or
TLb (0.1 to 5.0 µg) was compared. TLp treatment showed
a statistically significant difference HTase activity as com-
pared with treatment with TLb (Fig. 2B). TLp had a dose-
dependent stimulatory effect (0.1 µg to 1.0 µg) on HTase
activity (columns 6 to 8 in Fig. 2B), and more than 5.0 µg
produced saturation of this effect. In contrast, TLb had no
stimulating effect on HTase activity in the same dosage
range (columns 2 to 4, Fig. 2B).
On the other hand, PON1 activity in HDL was assayed
using paraoxyethyl as a substrate, and there was no change
upon the addition of TLp in the above dosage range (data
not shown). This finding suggests that other PON iso-
zymes may be responsible for TLp-induced HTase activa-
tion. The HTase/PON1 activity ratio calculated for each
HDL sample showed a dose-dependent elevation by TLp
(Fig. 3). One- and 5 µg of TLp gave a statistically signifi-
cant ratio increase as compared with lower amounts of
TLp. This suggests that TLp has no effect on the activities
of PON1, whereas it does have an effect on an isozyme
such as PON3.
Discussion
In previous studies, a PR diet was reported to lower the
elevation of blood glucose, type-1 plasminogen activator
inhibitor, and lipid peroxide concentrations in STZ-
induced diabetic rats [2,3]. This finding suggested that PR
intake can ameliorate diabetic vascular complications,
such as myocardial infarction, retinopathy, and nephrop-
athy.
(A) Effects of modified LDL on Na+/K+-ATPase activity Figure 2
(A) Effects of modified LDL on Na+/K+-ATPase activity. Activity was assayed by incubation with the following: 1, no additive; 2, 
LDL; 3, HT-treated LDL ; 4, TLb (0.1 µg)/HT-treated LDL; 5, TLb (1.0 µg)/HT-treated LDL; 6, TLb (10 µg)/HT-treated LDL; 7, 
TLp (0.1 µg)/HT-treated LDL; 8, TLp (1.0 µg)/HT-treated LDL ; 9, TLp (10 µg)/HT-treated LDL. (B) Effects of total lipid extract 
on HTase activity. Activity was assayed by incubation with the following: 1, no additive; 2, TLb (0.1 µg); 3, TLb (0.5 µg); 4, TLb 
(1.0 µg); 5, TLb (5.0 µg) ; 6, TLp (0.1 µg); 7, TLp (0.5 µg); 8, TLp (1.0 µg); 9, TLp (5.0 µg). Values are means ± SEM, n = 6 indi-
vidual experiments. The data values were analyzed by one-way ANOVA followed by Tukey's multiple comparison test. 
a,b,c,d,d,fValues with different superscript letters differ significantly among the columns at p < 0.05.Nutrition & Metabolism 2007, 4:25 http://www.nutritionandmetabolism.com/content/4/1/25
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We evaluated the effects of a PR diet on diabetic compli-
cations, especially peripheral neuropathy, in STZ-induced
diabetic rats. We found that PR and BR diets lowered
blood-glucose concentrations in diabetic rats, and that the
PR diet had a statistically significant blood-glucose lower-
ing effect (p < 0.01) as compared with the blood-glucose
levels measured in rats on the BR diet (Table 2).
Although the non-diabetic and STZ-diabetic groups ate
the same amount of diet, there was different gain in body
weight. As the total energy available from protein, fat, and
carbohydrate did not differ among the 3 diets (Table 1),
the same intake of diet suggests that STZ-diabetic rats can-
not sufficiently utilize the energy available from their diet.
We speculate that the STZ-treatment injured the insulin-
secreting beta cells, impairing glucose uptake into skeletal
muscle and resulting in weight loss. Alternatively, the
effect of STZ on hormonal functions of the adrenal glands
might enhanced the basal metabolic rate. In the STZ-dia-
betic rats, the concentrations of noradrenaline are known
to increase in a various tissues in these animals [31,32].
Thermogenesis is under control of the sympathetic nerv-
ous system, as noradrenaline has the ability to control
biochemical pathways that increases mitochondrial oxi-
dation rates and ATP synthesis, hence leading to an
increase in heat production and not leading to the gain in
body weight [33].
Our experiments showed that diabetic neuropathy was
induced by STZ-treatment at 5 weeks, as evidenced by
slowing of NCV and impairing of Na+/K+-ATPase activity
(Table 2), as well as to pathological changes consisting
mainly of axonal degeneration in the sciatic nerves of the
diabetic rats (data not shown). NCV values for all of the
experimental rats, including diabetic and non-diabetic
ones, correlated well with the sciatic-nerve membrane
Na+/K+-ATPase activity values of individual diabetic and
non-diabetic rats (Fig. 1). This result substantiated that
measurement of Na+/K+-ATPase activity provides an addi-
tional measure to NCV for evaluating the severity of
peripheral-nerve dysfunctions in animals. In our current
study, the efficacy of the PR diet also was confirmed by
morphometric analysis showing that axonopathy pre-
dominates over myelinopathy in STZ-diabetic rats. Abnor-
mal fibers undergoing axonal degenerative changes and
myelin breakdown are reported to appear in the sciatic
[34] and phrenic [35] nerves of STZ-induced diabetic rats
during prolonged hypoglycemia. Skewing of the G ratio
was corrected by the PR diet, giving an axonal diameter
distribution similar to that for the non-diabetic animals.
Serum Hcy is a known risk factor for vascular disease and
neurodegenerative disease [36] because an excess amount
of Hcy generates HT with high toxicity [37]. Abnormal
serum Hcy concentrations also have been observed in dia-
betic patients who develop peripheral vascular diseases. In
our study, the total serum homocysteine of the DC group
showed a decrease to 52.4% of the level for the C group
(Table 2), a finding in agreement with those of previous
studies [38-40]. The increase in serum creatinine in the
DC group was probably due to complications caused by
renal failure. The decrease in serum Hcy may have been
produced by abnormal renal clearance. There is a possibil-
ity that in the beginning stages of STZ-induced diabetes,
hepatic trans-sulfuration and re-methylation of the
enzymes cystathionine β-synthase and cystathionine γ-
lyase may increase in STZ-induced diabetic animals due to
lack of insulin [40].
Although in our study the Hcy level decreased in the DC
group, PR intake normalized the serum Hcy level as com-
pared with that seen in WR- or BR-intake. Serum PON 1
activity decreases in STZ-induced diabetic rats [20] and in
patients with vascular complications caused by type 2 dia-
betes mellitus [21,41-43]. PON has 3 isozymes, PON1,
PON2, and PON3, which have distinct substrate specifici-
ties and tissue localization [17]. PON1 is associated with
HDL and has been shown to reduce LDL susceptibility to
lipid peroxidation. PON2 does not appear in serum.
Whether the total HTase activity in human sera are
affected by PON3 activity has not yet been determined
[44]. PON1 is the only enzyme capable of hydrolyzing
paraoxon, a metabolite of organophosphate parathion.
PON1, PON2, and PON3, however, have the ability to
hydrolyze a number of acyl-homocysteine thiolactone
molecular species [17]. Serum Hcy produces HT that is
Effects of TLp on the ratio of HTase/PON1 activities Figure 3
Effects of TLp on the ratio of HTase/PON1 activities. HTase 
and PON 1 activities of HDL were assayed by incubation 
with the following: 1, no additive; 2, TLp (0.1 µg); 3, TLp (0.5 
µg); 4, TLp (1.0 µg); 5, TLp (5.0 µg). HTase activity corre-
sponds to combined enzyme activities of PON1 and PON3. 
Values are mean ± SEM in individual experiments (n = 6). The 
data were analyzed by one-way ANOVA followed by Tukey's 
multiple comparison test. a,bValues with different superscript 
letters differ significantly among the columns at p < 0.05.Nutrition & Metabolism 2007, 4:25 http://www.nutritionandmetabolism.com/content/4/1/25
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toxic to the vascular system in diabetes. The activity of
PON1 in serum and that of HTase in HDL decreased in
STZ-induced diabetic rats, as reported previously [20,21].
Diabetic rats on a PR diet showed significant attenuation
of PON1 and HTase activities as compared with those on
a control diet. There is a significant correlation of both
enzyme activities in diabetic rats on PR and BR diets.
Interestingly, there also is a highly significant correlation
between HTase and Na+/K+-ATPase activities of diabetic
rats on a PR, but not a BR, diet. The significant association
between these two enzymes may reflect the greater effec-
tiveness of PR than of BR intake.
To investigate whether PR has an active factor(s) making
it more effective than BR, Na+/K+-ATPase activity was
examined after incubation with HT-treated LDL and total
lipids extracted from PR and BR brans (TLp and TLb,
respectively). We found a significant decrease in Na+/K+-
ATPase activity on incubation with HT-modified LDL as
compared with incubation with intact LDL (p < 0.05) (Fig.
2A). Hcy has been reported to produce oxidative stress in
rat hippocampal neurons by inhibiting Na+/K+-ATPase
activity [14,15]. Vignini et al. [16] reported that HT-mod-
ified LDL attenuates Na+/K+-ATPase activity in cultured
human aortic endothelial cells. We obtained a similar
finding for the peripheral nervous system of diabetic rats.
In our experiment, TLp (0.1 to 10 µg)/HT-modified LDL
gave a weak inhibition of Na+/K+-ATPase activity, whereas
TLb/HT-modified LDL gave the same inhibition of Na+/
K+-ATPase activity as did HT-modified LDL. Neither TLp
nor TLb alone produced any modification of Na+/K+-
ATPase activity (data not shown). This finding may sug-
gest that TLp bears an inhibitory factor(s) that causes dep-
rivation or attenuation of the effect of HT-treated LDL on
Na+/K+-ATPase activity. This finding also may help to clar-
ify the mechanism of the amelioration of diabetic neurop-
athy by PR intake. We demonstrated that TLp also directly
enhanced the HTase activity of HDL (Fig. 2B). To estimate
the enzyme activity ratio of PON3 to PON1+PON3, we
assayed each enzyme activity by a substrate specificity of
PON1 and HTase. The enzyme activity ratio of PON1 to
HTase (Fig. 3) suggests that this enhancement may be due
to the PON 3 present in HDL. PON3 is an HDL-related
glycoprotein with multi-enzymatic properties and anti-
oxidant activity, considered to aid in preventing LDL oxi-
dation. PON3 bears many conserved phosphorylation
and N-glycosylation consensus sites [45]. Modification at
any of the sites required for activity in vivo, however, has
yet to be shown. Possibly, PON3 protein has a hydropho-
bic binding site(s) against a lipid that regulates its activity.
It is also possible that a certain unknown lipid component
in PR may bind to PON3 and activate it. PR is expected to
lower the postprandial blood-glucose increase, as is BR as
compared with WR. Our research suggests that this effi-
cacy may be based on higher concentrations of dietary
fiber in BR and PR as compared with the fiber in WR. The
PR diet includes almost the same amount of dietary fiber
as BR. Our study showed, however, that the PR diet low-
ered rat blood-glucose levels significantly more than did
BR (Table 2). Thus, compared with the BR diet, except for
lowering of the blood-glucose level, which may be due to
another PR intake mechanism, the PR diet mitigates dia-
betic neuropathy and is much more effective in easing
peripheral nerve dysfunction.
Conclusion
We found that PR-diet intake in STZ-induced diabetic rats
provided protection against deterioration of the periph-
eral nerve. An HTase-related mechanism contributed to
the improvement of diabetic neuropathy. The total lipid
extract of PR protected Na+/K+-ATPase from toxic HT-
modified LDL and enhanced HTase activity of HDL. This
protection could contribute to the efficacy of the PR diet
in ameliorating the deleterious effects of diabetic neurop-
athy
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